Cannabichromene

CAS No. 20675-51-8

Cannabichromene( Cannabichrome )

Catalog No. M23926 CAS No. 20675-51-8

Cannabichromene is a major non-psychotropic phytocannabinoid that inhibits endocannabinoid inactivation and activates the transient receptor potential ankyrin-1 (TRPA1).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 523 In Stock
5MG 410 In Stock
10MG 597 In Stock
25MG 937 In Stock
50MG 1228 In Stock
100MG 1665 In Stock
200MG Get Quote In Stock
500MG 3339 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Cannabichromene
  • Note
    Research use only, not for human use.
  • Brief Description
    Cannabichromene is a major non-psychotropic phytocannabinoid that inhibits endocannabinoid inactivation and activates the transient receptor potential ankyrin-1 (TRPA1).
  • Description
    Cannabichromene is a major non-psychotropic phytocannabinoid that inhibits endocannabinoid inactivation and activates the transient receptor potential ankyrin-1 (TRPA1), it selectively reduces inflammation-induced hypermotility in vivo in a manner that is not dependent on cannabinoid receptors or TRPA1.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Cannabichrome
  • Pathway
    GPCR/G Protein
  • Target
    Cannabinoid Receptor
  • Recptor
    CB2
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    20675-51-8
  • Formula Weight
    314.5
  • Molecular Formula
    C21H30O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CCCCCc1cc(OC(C)(CCC=C(C)C)C=C2)c2c(O)c1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.The effect of cannabichromene on adult neural stem/progenitor cells. Neurochem Int. 2013 Nov;63(5):432-7.
molnova catalog
related products
  • Tetrahydrocannabivar...

    Tetrahydrocannabivarin is a neutral cannabis receptor subtype (CB1) receptor antagonist, it can increases neural responding to rewarding and aversive stimuli, this effect profile suggests therapeutic activity in obesity, perhaps with a lowered risk of depressive side effects. Tetrahydrocannabivarin exhibits anticonvulsant effects in a piriform cortical brain slice model of epileptiform activity.

  • NESS-0327

    A potent, selective CB1 cannabinoid receptor antagonist with Ki of 350 fM.

  • JD-5037

    A selective, peripherally restricted cannabinoid-1(CB1) receptor blocker with IC50 of 1.5 nM.